Page last updated: 2024-09-04

moxifloxacin and Aortic Aneurysm

moxifloxacin has been researched along with Aortic Aneurysm in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's3 (100.00)2.80

Authors

AuthorsStudies
Dohgu, S; Inada, K; Koga, M; Yamada, A; Yamauchi, A1
Bennett, AC; Bennett, CL; Witherspoon, BJ1
Frassineti, GL; Monti, M; Ruscelli, S; Silimbani, P1

Other Studies

3 other study(ies) available for moxifloxacin and Aortic Aneurysm

ArticleYear
Moxifloxacin induces aortic aneurysm and dissection by increasing osteopontin in mice.
    Biochemical and biophysical research communications, 2022, 11-12, Volume: 629

    Topics: Angiotensin II; Animals; Anti-Bacterial Agents; Aortic Aneurysm; Aortic Dissection; Disease Models, Animal; Elastin; Eosine Yellowish-(YS); Hematoxylin; Male; Matrix Metalloproteinase 2; Mice; Mice, Inbred C57BL; Moxifloxacin; Muscle Proteins; Myocytes, Smooth Muscle; Osteopontin; Rubber; Water

2022
Response to: letter to the editor: consideration on 'an evaluation of reports of ciprofloxacin, levofloxacin, and moxifloxacin association neuropsychiatric toxicities, long-term disability, and aortic aneurysms/dissections disseminated by the food and dru
    Expert opinion on drug safety, 2020, Volume: 19, Issue:8

    Topics: Animals; Aortic Aneurysm; Ciprofloxacin; Dissection; Humans; Idiopathic Pulmonary Fibrosis; Levofloxacin; Moxifloxacin; United States; United States Food and Drug Administration

2020
Letter to the Editor: Consideration on "An evaluation of reports of ciprofloxacin, levofloxacin, and moxifloxacin- association neuropsychiatric toxicities, long-term disability, and aortic aneurysms/dissections disseminated by the Food and Drug Administra
    Expert opinion on drug safety, 2020, Volume: 19, Issue:8

    Topics: Aortic Aneurysm; Ciprofloxacin; Dissection; Fluoroquinolones; Humans; Levofloxacin; Moxifloxacin; United States; United States Food and Drug Administration

2020